AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

PARADIGM BIOPHARMACEUTICALS-WS

0.001

0.000

Volume:- -

Turnover:- -

Market Cap:439.00K

PE:-0.02

High:0.001

Open:0.001

Low:0.001

Close:0.001

52wk High:0.140

52wk Low:0.001

Shares:439.00M

Float Shares:367.00M

Volume Ratio:- -

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.047

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Company Profile

Company Name:

PARADIGM BIOPHARMACEUTICALS-WS

Exchange:

ASX

Establishment Date:

- -

Employees:

- -

Office Location:

- -

Website:

http://www.paradigmbiopharma.com

Zip Code:

- -

Phone:

- -

Fax:

- -

Introduction:

Paradigm Biopharmaceuticals Limited, a biopharmaceutical company, engages in the research and development of therapeutic products for human use in Australia. It offers pentosan polysulphate sodium drugs in the injectable and tablet forms for the treatment of bone marrow edema, respiratory, and alphaviral arthritis diseases. The company was incorporated in 2014 and is based in Melbourne, Australia.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/PAROA.AU/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"PAROA.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"PAROA.AU\",,,,,undefined,":{"symbol":"PAROA.AU","market":"AU","secType":"WAR","nameCN":"PARADIGM BIOPHARMACEUTICALS-WS","latestPrice":0.001,"timestamp":1773982800000,"preClose":0.001,"halted":0,"volume":0,"delay":0,"changeRate":0,"strike":0.65,"lastTradingDate":1770728400000,"nameEN":"PARADIGM BIOPHARMACEUTICALS-WS","floatShares":367000000,"shares":438999999,"eps":-0.04697,"marketStatus":"Market Closed","change":0,"latestTime":"03-20 16:00:00 AEDT","open":0.001,"high":0.001,"low":0.001,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.04697,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1774220400000},"marketStatusCode":7,"adr":0,"exchange":"ASX","adjPreClose":0.001,"volumeRatio":0,"lotSize":1,"tradeCurrency":"AUD","type":1,"expireDate":1770728400000,"ul":"PAR.AU","ulStockBrief":{"symbol":"PAR.AU","market":"AU","secType":"STK","nameCN":"PARADIGM BIOPHARMACEUTICALS","latestPrice":0.27,"timestamp":1773983520000,"preClose":0.26,"halted":0,"volume":801413,"delay":0},"auctionPricing":{"symbol":"PAROA.AU","preClose":0.002,"auctionPrice":0.002,"auctionVolume":116270,"auction":3,"marketStatus":"盘后竞价","timestamp":1770267600684}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"PAROA.AU\",,,,,undefined,":{"symbol":"PAROA.AU","floatShares":367000000,"roa":"--","roe":"--","lyrEps":0,"shares":438999999,"dividePrice":0,"high":0.001,"amplitude":0,"preClose":0.001,"low":0.001,"week52Low":0.001,"pbRate":"--","week52High":0.14,"institutionHeld":0,"latestPrice":0.001,"eps":-0.04697,"divideRate":0,"volume":0,"delay":0,"ttmEps":-0.04697,"open":0.001,"prevYearClose":0.01,"prevWeekClose":0.001,"prevMonthClose":0.001,"prevQuarterClose":0.01,"fiveDayClose":0.001,"twentyDayClose":0.001,"sixtyDayClose":0.015},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PAROA.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PAROA.AU\",market:\"AU\",,,undefined,":[],"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.paradigmbiopharma.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":-0.9333},{"period":"6month","weight":-0.9722},{"period":"1year","weight":-0.9931},{"period":"ytd","weight":-0.9}],"compareEarnings":[{"period":"1week","weight":-0.0205},{"period":"1month","weight":-0.0535},{"period":"3month","weight":-0.0337},{"period":"6month","weight":0.0157},{"period":"1year","weight":0.0973},{"period":"ytd","weight":-0.0408}],"compareStock":{"symbol":"F100.AU","name":"BETASHARES FTSE 100 ETF"},"description":"Paradigm Biopharmaceuticals Limited, a biopharmaceutical company, engages in the research and development of therapeutic products for human use in Australia. It offers pentosan polysulphate sodium drugs in the injectable and tablet forms for the treatment of bone marrow edema, respiratory, and alphaviral arthritis diseases. The company was incorporated in 2014 and is based in Melbourne, Australia.","exchange":"ASX","name":"PARADIGM BIOPHARMACEUTICALS-WS","nameEN":"PARADIGM BIOPHARMACEUTICALS-WS"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"PAROA.AU\",market:\"AU\",,,undefined,":null}}